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Introduction
Human glutamate carboxypeptidase II (GCPII) is a type II membrane glycoprotein with an approximate molecular weight of 90-100 kDa. The mature full-length protein consists of 750 amino-acid residues. A short N-terminal fragment (residues 1-19), located in the cytoplasm, is followed by a single transmembrane segment and the 707-amino-acid ectodomain, which faces the extracellular milieu. GCPII is a homodimeric metallopeptidase that utilizes two zinc ions to cleave a C-terminal residue from peptidic substrates (Rawlings & Barrett, 1997) . The only recognized natural substrates of GCPII to date are N-acetyl-aspartyl-glutamate (NAAG) and folyl-poly--glutamates; i.e. peptides harboring glutamate at the C-terminus (Pinto et al., 1996; Robinson et al., 1987) .
In healthy individuals, GCPII is expressed predominantly in the central nervous system and on the brush-border membrane of the proximal small intestine (Š á cha et al., 2007; Troyer et al., 1995) . In the latter compartment GCPII participates in the absorption of dietary folates (Halsted et al., 1998) , while the neural form of the enzyme modulates neurotransmission by NAAG hydrolysis and the concomitant glutamate release (Robinson et al., 1987) . Inhibition of GCPII peptidase activity showed efficacy under pathological conditions associated with dysregulated glutamatergic transmission, such as in experimental models of pain, brain injury or amyotrophic lateral sclerosis (for a recent review, see Neale et al., 2005 and references therein). Since GCPII expression is highly upregulated in the neovasculature of solid tumors as well as in prostate cancer (Bostwick et al., 1998) , the enzyme is an obvious target for the treatment and imaging of these malignancies (Gao et al., 1997) . Consequently, potent and selective small-molecule inhibitors or functionalized ligands of the enzyme are being developed and tested in preclinical settings (Zhou et al., 2005 and references therein).
The recently reported crystal structures of the human GCPII ectodomain in complex with glutamate, phosphate and GPI-18431 (PDB codes 2c6g, 2c6p and 2c6c, respectively) have revealed the presence of three GCPII subdomains, protease-like (residues 57-116 and 352-590), apical (residues 117-351) and C-terminal (residues 591-750), and it was noted that cooperation between all three subdomains is required for efficient substrate binding and hydrolysis. Furthermore, detailed analysis of the structures led to the hypothesis of an induced-fit mechanism of substrate recognition by GCPII, in which the 15/16 hairpin (residues 692-704; termed the 'glutarate sensor') probes the S1 0 pocket for the presence or absence of glutamate (Mesters et al., 2006) . In addition to the above-mentioned moderate-resolution X-ray structures of GCPII complexes, Davis and coworkers also published the X-ray structure of ligand-free GCPII (GCPII old ; PDB code 1z8l) refined to 3.5 Å resolution (Davis et al., 2005) .
Therefore, a ligand-free structure of recombinant human GCPII (rhGCPII new ) refined at a resolution of 1.65 Å and reported here represents a marked improvement in the quality of the model and allows the accurate description of the GCPII active site in the absence of ligands. This information will be significant in the elucidation of the mechanism of substrate hydrolysis by human GCPII and will permit the description of the conformational changes accompanying substrate/inhibitor binding.
Materials and methods

Expression and purification of rhGCPII
An extracellular part of human GCPII (rhGCPII new ; amino acids 44-750) was heterologously overexpressed in Drosophila Schneider S2 cells and purified to homogeneity as described previously (Barinka et al., 2002) . Briefly, the recombinant protein was purified from conditioned medium by a succession of ion-exchange, affinity and size-exclusion chromatographies. The final protein preparation was >97% pure, as determined by Coomassie-staining SDS-PAGE (data not shown). The protein was extensively dialyzed against 100 mM NaCl, 20 mM Tris-HCl pH 8.0, concentrated to 10 mg ml À1 and stored at 193 K.
Crystallization and diffraction data collection
Initial crystallization screening was performed using a Hydra II robot (Apogent Discoveries, Hudson, USA) and a sitting-drop vapordiffusion setup, with the rhGCPII at concentration of 10 mg ml À1 . The final crystallization solution was composed of 33%(v/v) pentaerythritol propoxylate PO/OH 5/4, 1-3%(w/v) PEG 3350 and 100 mM Tris-HCl pH 8.0. For data collection, rhGCPII crystals were grown in hanging drops formed by mixing equal volumes of the protein and crystallization solutions. 2 ml drops were equilibrated against 1 ml reservoir solution at 293 K and crystals of approximate dimensions 0.5 Â 0.5 Â 0.2 mm grew within several weeks. Prior to X-ray exposure, crystals taken directly from the drop were cryopreserved in liquid nitrogen. The diffraction pattern was collected from a single crystal at the SER-CAT beamline (sector 22-BM) at the Advanced Photon Source (Argonne, Illinois, USA) equipped with a MAR Research CCD detector using a 1.000 Å wavelength. The measurements were conducted at 100 K. All data were integrated and scaled with the HKL-2000 program suite (Otwinowski & Minor, 1997) and the appropriate X-ray data statistics are summarized in Table 1 .
Structure determination and refinement
Because of the identical symmetry and very similar unit-cell parameters of the rhGCPII-glutamate (PDB code 2c6g) and rhGCPII new crystals, the structure solution was limited to rigid-body refinement of the rhGCPII-glutamate model (without water molecules and the S1 0 -bound glutamate) against the rhGCPII new diffraction intensities. This procedure, which was conducted at 2.5 Å resolution, was followed by the refinement of atomic coordinates and B factors with a gradual extension of the resolution to the limit of the experimental data (1.65 Å ). Calculations were performed with the program REFMAC v.5.1 (Murshudov et al., 1999) . The refinement protocol was interspersed with manual corrections to the model using the computer-graphics program O (Jones et al., 1991) . During the refinement, a randomly selected 5% of the reflections were kept aside for cross-validation (R free ). The final values of the R factor and R free were 0.207 and 0.228, respectively, for data in the resolution range 30-1.65 Å . Detailed statistics for the refined structure are given in Table 1 .
Results and discussion
Screening and crystallization
The main problem limiting the resolution of the previously reported structures of GCPII was the lack of suitable conditions for freezing the crystals prior to X-ray exposure. To address this issue, we revised the crystallization conditions for rhGCPII using several crystallization screens from commercial sources. The final selection of a mother liquor composed of 33%(v/v) pentaerythritol propoxylate cryopreservation of rhGCPII new crystals for experiments without a visible loss in diffraction quality. It should be noted that the recently published structure of ligand-free GCPII old was crystallized in space group P2 1 , which is different from both the crystal form presented here and the crystal forms of the above-mentioned rhGCPII complexes.
Overall structure
The 1.65 Å model of ligand-free rhGCPII new consists of 5946 non-H protein atoms (686 amino-acid residues), 561 water O atoms, one Ca 2+ ion, one Cl À ion and two Zn 2+ ions. Most of the protein residues are well defined in the electron-density peaks. The exceptions are the first 13 N-terminal residues and a flexible loop (541-547), which could not be modeled owing to the lack of corresponding electron-density data. Since these fragments do not interact with neighboring molecules, their high flexibility is probably a property native to rhGCPII. The only other fragment not modeled in the rhGCPII new structure is the short (654-656) loop that directly interacts with an equivalent fragment from a symmetry-related molecule. Despite strong positive F o À F c peaks, we were unable to deconvolve the alternate conformations for this fragment. Two alternate conformations were modeled for the side chains of 34 residues, based on the F o À F c electron-density peaks. Unless the intensities of these peaks clearly indicated otherwise, equal occupancies were assumed for the alternate conformations. Additionally, two partially occupied main-chain conformations were evident for the protein segment 692-704. The conformational adaptability of this fragment has been suggested as being important for substrate recognition and/or binding (Mesters et al., 2006) . The Ramachandran analysis of the final model using the program PROCHECK (Laskowski et al., 1993) classifies 89.2% of the residues as having the most favorable conformations, with 10.6% of the residues adopting allowed conformations. Despite being clearly defined by the electron-density maps, Lys207 adopts a conformation that is disallowed by Ramachandran analysis.
A comparison of the resulting structure with the previously reported 3.5 Å structure of ligand-free GCPII old reveals the structures to be fairly similar, with an r.m.s. deviation between the 685 equivalent C atoms of 1.23 Å . Likewise, the overall fold of ligandfree rhGCPII new is almost indistinguishable from the structures of rhGCPII complexed with reaction products/inhibitors.
The active site
Two zinc ions located in the active site of rhGCPII new are bridged by the -carboxylate of Asp387 and are further coordinated by the side chains of His377, Asp453, Glu425 and His553. In the structure of rhGCPII new , an activated water molecule (or OH À ) is located symmetrically between the two Zn 2+ ions at distances of 2.03 and 2.01 Å . This water molecule plays a central role in the hydrolysis of a substrate and is hydrogen bonded to the conserved Glu424 residue (OÁ Á ÁOE1, 2.92 Å ) that functions as a proton shuttle during scissile bond cleavage. A similar arrangement of the active site has been reported previously for the ligand-free GCPII old , although the interatomic distances between the activated water and Glu424 -carboxylate were too long ($3.8 Å ) for efficient proton transfer (Davis et al., 2005) .
The substrate-binding cavity
The S1 0 pocket of GCPII is defined by residues Phe209, Arg210, Asn257, Gly427, Leu428, Gly518, Lys699 and Tyr700. The latter two are part of a flexible 'glutarate sensor' (Mesters et al., 2006) . The positions of most of the residues lining the S1 0 pocket are similar in the GCPII old and rhGCPII new structures. The exceptions are the amino acids from the glutarate sensor (Lys699 and Tyr700) and the side chain of Phe209. The Phe209 side chain is rotated by $120 between rhGCPII new and GCPII old , resulting in a shift of $8 Å between the CZ atoms of the two models. The different conformation of Phe209 in GCPII old might reflect a natural positional flexibility of this residue; however, Phe209 adopts an invariable conformation (as observed in rhGCPII new ) in all other reported structures of GCPII.
The S1 0 pocket in rhGCPII new is occupied by a network of six water molecules. Four of these molecules (one in two alternate positions) occupy the approximate positions of the N, OXT, CB, OE1 and OE2 atoms of a glutamate ligand in the rhGCPII-glutamate complex (Mesters et al., 2006) , while the fifth water is conserved in both the complex and rhGCPII new . The sixth water forms hydrogen bonds to Tyr552 OH (2.62 Å ) and His553 NE2 (3.09 Å ) and coordinates the Zn 2+ ion at 2.48 Å .
The bottom of the S1 0 pocket is closed by a flexible loop formed by residues 692-704 (the 'glutarate sensor'). Two residues from this loop (Lys699 and Tyr700) interact directly with a C-terminal residue of a substrate in the GCPII complexes and the glutarate sensor can adopt various conformations, largely depending on the occupancy of the S1 0 pocket (Mesters et al., 2006; Davis et al., 2005) . Two conformations of the glutarate sensor were modeled in the rhGCPII new structure, with a maximal positional difference of $6 Å (C atoms of Gly702). An ensemble of the variable conformations of the glutarate sensor is shown in Fig. 1 , where the published structures of GCPII are superimposed on the model of rhGCPII new .
The putative S1 pocket is defined by residues Ser454, Glu457, Asp465, Asn519, Gly548, Tyr549 and Tyr552, as well as by a stack of three arginines (Arg463, Arg534 and Arg536). This positively charged arginine stack, located 6.5-12.7 Å from the nearest Zn 2+ ion, Ensemble of conformations of the 'glutarate sensor'. Two residues in this segment, Lys699 and Tyr700, interact directly with the ligands of the S1 0 site. The GCPII structures available from the PDB were superimposed on the structure of rhGCPII new . The C traces are shown in ribbon representation, the active-site Zn +2 ions are shown as blue spheres and the yellow sphere represents the S1-bound Cl À ion. The 'glutarate sensor' is shown in yellow for PDB entry 1z8l, in magenta for 2c6g, in blue for 2c6p and in red and cyan for the two conformations in rhGCPII new . The S1 and S1 0 sites are highlighted by gray ellipses. is believed to be responsible for the enzyme's preference for negatively charged residues in the penultimate (i.e. P1) position of a substrate (Barinka et al., 2002; Mesters et al., 2006) . The invariant positions of the guanidinium groups in Arg534 and Arg463 are maintained by interaction with a Cl À ion and a strong hydrogen bond (2.59 Å ) to the -carboxylate of Glu457, respectively. The side chain of Arg536 adopts two conformations. In the slightly more abundant conformation, the guanidinium group of Arg536 forms two hydrogen bonds to Ser454 OG (NH1Á Á ÁOG, 3.21 Å ; NH2Á Á ÁOG, 3.24 Å ) and one to Ser454 O (3.03 Å ), Glu457 OE1 (2.85 Å ) and Cl À (3.26 Å ) (Fig. 2) . Thus, the role of the Cl À ion is in stabilizing the positions of Arg534 and Arg536 and in neutralizing the combined positive charge of their guanidinium groups. It has been suggested that the chloride ion is essential for GCPII hydrolytic activity (Robinson et al., 1987) . In the less occupied conformation, the stabilization of the guanidinium group of Arg536 provided by stacking between Arg463 and Arg534 is further stabilized by ionic interactions with the negatively charged carboxylate of Asp465.
Conclusions
In summary, our newly established crystallization conditions allowed us to determine and refine the structure of ligand-free rhGCPII new at a resolution of 1.65 Å . A comparison with the GCPII old model reveals several marked differences in the organization of the substratebinding cavity of this enzyme. Thus, the present structure could serve as a more accurate model for ensuing biochemical/structural studies.
